Enhanced in vivo anti-tumor activity and cytokine production was also found in human MART-1 TCR T cells expressing a CSR based on TIGIT (TIGIT:CD28) in a human melanoma xenograft mouse model [222]. The gene discussed is TIGIT; the disease is neoplasm.